fullscreen

eFinder

eFinder

Home › Article

The evolution of HIV treatment: From multi-pill regimens to better, single-pill combos

Daily Maverick · 🇿🇦 public South Africa · · 2398 words · By Elri Voigt
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about The evolution of HIV treatment: From multi-pill regimens to better, single-pill combos

Twenty years ago, antiretroviral treatment involved taking a number of pills, sometimes many times a day.

Claims checked 19
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center100%
Right0%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Twenty years ago, antiretroviral treatment involved taking a number of pills, sometimes many times a day.

Why it matters

Though these medicines saved many lives, they did cause a variety of side-effects, and many people developed resistance to some of the drugs.

Common ground

Since then we’ve seen significant scientific advances.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.dailymaverick.co.za/article/2026-06-01-the-evolution-of-hiv-treatmen…

fact_checkClaims Checked

eFinder analyzed this article and checked 19 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 9
check_circle Corroborated 7
help Insufficient Evidence 2
info Single Source 1
info
Claim 1: “This regimen, a combination of the drugs tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), is still the backbone of South Africa’s HIV treatment programme, with more than five million people taking it every day.”
SINGLE SOURCE
While sources confirm TLD is a combination of tenofovir disoproxil fumarate, lamivudine, and dolutegravir and is used globally, the specific claim that 'more than five million people' in South Africa take it daily is not explicitly corroborated by the provided evidence. One source mentions 25 million people globally, but not the specific South African figure.
menu_book
wikipedia NEUTRAL — The domain com is a top-level domain (TLD) in the Domain Name System (DNS) of the Internet. Created in the first group of Internet domains in March of 1985, it is short for commercial, as it was origi…
https://en.wikipedia.org/wiki/.com
menu_book
wikipedia NEUTRAL — Generic top-level domains (gTLDs) are one of the categories of top-level domains (TLDs) maintained by the Internet Assigned Numbers Authority (IANA) for use in the Domain Name System of the Internet. …
https://en.wikipedia.org/wiki/Generic_top-level_domain
menu_book
wikipedia NEUTRAL — South Africa, officially the Republic of South Africa (RSA), is the southernmost country in Africa. Its nine provinces are bounded to the south by 2,798 kilometres (1,739 miles) of coastline that stre…
https://en.wikipedia.org/wiki/South_Africa
+ 3 more evidence sources
schedule
Claim 2: “the drugs most commonly used to treat HIV inhibit one of three important enzymes HIV uses to replicate. These are: reverse transcriptase, integrase and protease.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 3: “The regimen most people living with HIV in South Africa are on, TLD, contains two NRTIs (tenofovir disoproxil fumarate and lamivudine) and an INSTI (dolutegravir).”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 4: “In the study, 186 people stayed on their existing regimen and 371 were switched to the bictegravir and lenacapavir pill.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results regarding the specific split of 186 people on existing regimens and 371 switched to the new pill.
check_circle
Claim 5: “The study looked at 557 adults who were already taking a complex HIV regimen”
CORROBORATED
Evidence from the ARTISTRY-1 study results confirms the enrollment of 557 adults who were taking complex regimens (specifically mentioning those including a PI).
travel_explore
web search NEUTRAL — Feb 25, 2026 ... v on behalf of the ARTISTRY-1 Study Group. ARTISTRY-1 Study Group ... 557 were taking a regimen that included a PI. The most common ...
https://www.thelancet.com/journals/lancet/article/PIIS0140-6…
travel_explore
web search NEUTRAL — Mar 6, 2026 ... The study investigators conducted a Phase 3, randomized, open-label clinical trial (called ARTISTRY-1) among adults living with HIV who were ...
https://www.thebodypro.com/hiv/bictegravir-lenacapavir-compl…
travel_explore
web search NEUTRAL — Mar 28, 2026 ... Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.
https://pubmed.ncbi.nlm.nih.gov/41763229/
check_circle
Claim 6: “In 2013, the government introduced a one pill, once a day regimen as the standard first-line treatment.”
CORROBORATED
Multiple web search results confirm that South Africa adopted a once-daily single-pill HIV treatment regimen as the standard of care in April 2013.
menu_book
wikipedia NEUTRAL — HIV/AIDS is one of the most serious health concerns in South Africa. South Africa has the highest number of people afflicted with HIV of any country, and the fourth-highest adult HIV prevalence rate, …
https://en.wikipedia.org/wiki/HIV/AIDS_in_South_Africa
menu_book
wikipedia NEUTRAL — In South Africa, HIV/AIDS denialism had a significant impact on public health policy from 1999 to 2008, during the presidency of Thabo Mbeki. Mbeki criticized the scientific consensus that HIV is the …
https://en.wikipedia.org/wiki/HIV/AIDS_denialism_in_South_Af…
menu_book
wikipedia NEUTRAL — South Africa's HIV/AIDS epidemic, which is among the most severe in the world, is concentrated in its townships, where many black South Africans live due to the lingering effects of the Group Areas Ac…
https://en.wikipedia.org/wiki/HIV/AIDS_in_South_African_town…
+ 3 more evidence sources
schedule
Claim 7: “the country’s 2023 national guidelines cleared the way for most people living with HIV currently on treatment to be switched to TLD, regardless of their treatment history.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 8: “of the 557 people enrolled, Orkin said more than half had at least two comorbidities, and 60% of the participants were taking two or more concomitant medications to treat these comorbidities.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results regarding the specific percentages of comorbidities (over 50%) or concomitant medications (60%) mentioned by 'Orkin'.
check_circle
Claim 9: “The bictegravir and lenacapavir pill was found to be non-inferior (meaning roughly as good as) to the complex regimens, and no drug resistance was seen.”
CORROBORATED
Multiple sources explicitly state that the bictegravir-lenacapavir combination was non-inferior to complex regimens and showed no treatment-emergent drug resistance.
travel_explore
web search NEUTRAL — Feb 25, 2026 ... ... 1); no deaths were deemed related to study drug. ... lenacapavir was non-inferior to complex regimens in maintaining HIV-1 suppression.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6…
travel_explore
web search NEUTRAL — Mar 6, 2026 ... The study demonstrated: Virologic non-inferiority (approximately 1% virologic failure in each arm). No treatment-emergent drug resistance.
https://www.thebodypro.com/hiv/bictegravir-lenacapavir-compl…
travel_explore
web search NEUTRAL — Feb 25, 2026 ... Resistance analysis showed no treatment‑emergent resistance through ... drug-resistant HIV in adults, in combination with other antiretrovirals.
https://www.gilead.com/news/news-details/2026/gileads-single…
check_circle
Claim 10: “It [TLD] is also recommended by the World Health Organization for treatment of almost all people living with HIV.”
CORROBORATED
Evidence indicates that TLD is the World Health Organization's recommended first-line regimen.
menu_book
wikipedia NEUTRAL — The domain name org is a generic top-level domain (gTLD) of the Domain Name System (DNS) used for Internet services. The name is truncated from organization. It was one of the original domains establi…
https://en.wikipedia.org/wiki/.org
menu_book
wikipedia NEUTRAL — The United States is the largest donor of multilateral global health funds. According to the Office of Management and Budget, the U.S. government contributes <1% of the federal budget for foreign aid…
https://en.wikipedia.org/wiki/Global_health_funding_by_the_U…
menu_book
wikipedia NEUTRAL — Iran, officially the Islamic Republic of Iran, historically known as Persia, is a country in West Asia. It borders Iraq to the west, Turkey, Azerbaijan, and Armenia to the northwest, the Caspian Sea t…
https://en.wikipedia.org/wiki/Iran
+ 3 more evidence sources
schedule
Claim 11: “The drug lenacapavir is the best-known member of this drug class [capsid inhibitors].”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 12: “The study population, drawn from sites across 15 countries, including South Africa, were unique in that they had on average been taking treatment for 28 years”
CORROBORATED
Evidence confirms the median duration of HIV treatment for participants was 28 years and that the study spanned multiple countries, including Africa (with 21% of participants from Africa).
travel_explore
web search NEUTRAL — Feb 25, 2026 · Median duration of HIV treatment was 28 years, and a large percentage of participants (81%) were on a complex regimen due to antiretroviral ...
https://www.thelancet.com/journals/lancet/article/PIIS0140-6…
travel_explore
web search NEUTRAL — Mar 9, 2026 · With 116 study sites spanning 20 countries, the trial was relatively dispersed across the globe, including 21% of participants from Africa.
https://www.thebodypro.com/hiv/two-drug-antiretroviral-thera…
travel_explore
web search NEUTRAL — Dec 31, 2025 · Phase 3 results from Gilead Sciences about the ARTISTRY-1 study show the new bictegravir- lenacapavir combo as treatment for people with HIV ...
https://www.facebook.com/patientworthy/posts/gileads-dual-ac…
check_circle
Claim 13: “In 2019, first-line treatment was further strengthened when a breakthrough new antiretroviral drug called dolutegravir was included in a new daily combination pill.”
CORROBORATED
Multiple sources confirm that dolutegravir was included in a new first-line combination pill in South Africa in 2019.
menu_book
wikipedia NEUTRAL — Dolutegravir/lamivudine/tenofovir (DTG/3TC/TDF) is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It is a combination of dolutegravir, lamivudine, and tenofovir disoproxil.…
https://en.wikipedia.org/wiki/Dolutegravir/lamivudine/tenofo…
menu_book
wikipedia NEUTRAL — Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. It may also be used, as part of post exposure prophylaxi…
https://en.wikipedia.org/wiki/Dolutegravir
menu_book
wikipedia NEUTRAL — Dolutegravir/lamivudine, sold under the brand name Dovato, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. each pill contains 50 mg dolutegravir, as the salt, an i…
https://en.wikipedia.org/wiki/Dolutegravir/lamivudine
+ 3 more evidence sources
check_circle
Claim 14: “A phase three study, called ARTISTRY 1, published in the Lancet medical journal in February, looked at the safety and efficacy of a combination pill containing the drugs bictegravir and lenacapavir compared with several more complex HIV regimens.”
CORROBORATED
Multiple search results confirm the existence of the ARTISTRY-1 phase 3 study evaluating a bictegravir and lenacapavir combination pill against complex regimens, with publications appearing in February 2026.
menu_book
wikipedia NEUTRAL — The Cathedral of St. John the Divine (sometimes referred to as St. John's and also nicknamed St. John the Unfinished) is the cathedral of the Episcopal Diocese of New York. It is at 1047 Amsterdam Ave…
https://en.wikipedia.org/wiki/Cathedral_of_St._John_the_Divi…
menu_book
wikipedia NEUTRAL — To Pimp a Butterfly is the third studio album by the American rapper Kendrick Lamar. It was released on March 15, 2015, by Top Dawg Entertainment, Aftermath Entertainment and Interscope Records. The a…
https://en.wikipedia.org/wiki/To_Pimp_a_Butterfly
menu_book
wikipedia NEUTRAL — William Charles Utermohlen (December 5, 1933 – March 21, 2007) was an American figurative artist known for his late-period self-portraits completed after his diagnosis of probable Alzheimer's disease.…
https://en.wikipedia.org/wiki/William_Utermohlen
+ 3 more evidence sources
schedule
Claim 15: “As of December 2023, an estimated 77% of people with HIV worldwide were receiving ART [antiretroviral therapy], with more than 80% of these individuals being treated with tenofovir, lamivudine, and dolutegravir.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 16: “In this class [Protease inhibitors], a well-known drug is darunavir.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 17: “A well-known NRTI is the drug lamivudine, while a well-known NNRTI is efavirenz.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 18: “There were five deaths in the group taking the bictegravir and lenacapavir pill, but these were not related to the drug.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 19: “Bictegravir, raltegravir and dolutegravir fall into this drug class [Integrase strand transfer inhibitors].”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.